FDAClass IIAugust 30, 2023

NAD+ 200mg/ml recall: Sterility Concern

NAD+ 200mg/ml, 10ml vials, Tailor Made Compounding.

Why was NAD+ 200mg/ml recalled?

Lack of Assurance of Sterility

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot#: 07192307A2, BUD: 11/18/2023

Product
NAD+ 200mg/ml, 10ml vials, Tailor Made Compounding.
Recalling firm
TMC Acquisitions LLC dba Tailor Made Compounding
Quantity
99 vials
Distribution
Nationwide within the USA
Recall date
August 30, 2023
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls